Law360, New York (December 14, 2009, 6:38 PM ET) -- A magistrate judge has recommended that a court hold off on ruling whether AstraZeneca PLC procured a patent for cholesterol drug Crestor through inequitable conduct, potentially sending the issue to trial in an intellectual property dispute between the pharmaceutical giant and generics makers.
U.S. Magistrate Judge Leonard P. Stark issued an opinion Friday in the U.S. District Court for the District of Delaware recommending that Judge Joseph J. Farnan Jr. deny summary judgment to AstraZeneca on the inequitable conduct claims, and hinting that the generics makers...
Inequitable Conduct Still In Play In Crestor Suit
To view the full article, take a free trial now.
